tiprankstipranks
Advertisement
Advertisement

TOVX Stock Latest News

Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
The FlyTheriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
7d ago
TOVX
Theriva Biologics upgraded to Buy from Hold at Maxim
PremiumThe Fly
Theriva Biologics upgraded to Buy from Hold at Maxim
8d ago
TOVX
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
PremiumCompany Announcements
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
16d ago
8K
TOVX
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
PremiumThe Fly
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
16d ago
TOVX
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
PremiumThe Fly
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
25d ago
TOVX
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
PremiumThe FlyTheriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
27d ago
TOVX
Theriva Biologics sees cash runway into 1Q27
Premium
The Fly
Theriva Biologics sees cash runway into 1Q27
27d ago
TOVX
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
Premium
Company Announcements
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
2M ago
8K
TOVX
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
PremiumThe Fly
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
2M ago
TOVX
Theriva Biologics Faces Delay in Warrant Approval Meeting
PremiumCompany Announcements
Theriva Biologics Faces Delay in Warrant Approval Meeting
2M ago
8K
TOVX
Theriva Biologics advances VCN-01 toward Phase 3 trial
PremiumCompany Announcements
Theriva Biologics advances VCN-01 toward Phase 3 trial
3M ago
8K
TOVX
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
PremiumCompany Announcements
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
3M ago
8K
TOVX
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
PremiumThe FlyTheriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
3M ago
TOVX
Theriva Biologics Reschedules Special Stockholder Meeting
Premium
Company Announcements
Theriva Biologics Reschedules Special Stockholder Meeting
4M ago
8K
TOVX
Theriva Biologics Advances Oncology Pipeline with VCN-01
Premium
Company Announcements
Theriva Biologics Advances Oncology Pipeline with VCN-01
5M ago
TOVX
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
PremiumThe Fly
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
5M ago
TOVX
Theriva Biologics files to sell 16.18M shares of common stock for holders
PremiumThe Fly
Theriva Biologics files to sell 16.18M shares of common stock for holders
5M ago
TOVX
Theriva Biologics sees no material development to account for unusual trading
PremiumThe Fly
Theriva Biologics sees no material development to account for unusual trading
6M ago
TOVX
Theriva Biologics Presents Promising Phase 2b Trial Data
PremiumCompany Announcements
Theriva Biologics Presents Promising Phase 2b Trial Data
6M ago
8K
TOVX
Theriva Biologics Secures $4M Through Warrant Agreement
PremiumCompany AnnouncementsTheriva Biologics Secures $4M Through Warrant Agreement
6M ago
8K
TOVX
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
Premium
The Fly
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
6M ago
TOVX
Theriva Biologics Presents Promising Phase 2b Trial Data
Premium
Company Announcements
Theriva Biologics Presents Promising Phase 2b Trial Data
6M ago
8K
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >